TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP

BACKGROUND: Currently, how to successfully control refractory and metastatic diseases remains a fundamental goal for clinicians to improve therapeutic effects for patients with non-small cell lung cancer (NSCLC). Several studies have discovered that TRIM58, a member of tripartite motif protein famil...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Rongxin, Chen, Jiakuan, Gao, Yang, Chen, Jijun, Han, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836804/
https://www.ncbi.nlm.nih.gov/pubmed/36644609
http://dx.doi.org/10.1155/2023/5899662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836804/
https://www.ncbi.nlm.nih.gov/pubmed/36644609
http://dx.doi.org/10.1155/2023/5899662

Ejemplares similares